Back to top

earnings-performance: Archive

Zacks Equity Research

Why Is TEGNA (TGNA) Down 3.2% Since Last Earnings Report?

TEGNA (TGNA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Why Is Venture Global (VG) Down 12% Since Last Earnings Report?

Venture Global (VG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Westport (WPRT) Down 10.4% Since Last Earnings Report: Can It Rebound?

Westport (WPRT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Why Is Red Robin (RRGB) Down 9.8% Since Last Earnings Report?

Red Robin (RRGB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Starwood Property Trust (STWD) Up 0.9% Since Last Earnings Report: Can It Continue?

Starwood Property Trust (STWD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Theravance Bio (TBPH) Down 3.7% Since Last Earnings Report: Can It Rebound?

Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Immunovant (IMVT) Down 0.6% Since Last Earnings Report: Can It Rebound?

Immunovant (IMVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Why Is Ironwood (IRWD) Up 24.9% Since Last Earnings Report?

Ironwood (IRWD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Rigetti Computing (RGTI) Down 10.1% Since Last Earnings Report: Can It Rebound?

Rigetti Computing (RGTI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Why Is CRISPR Therapeutics (CRSP) Up 3.3% Since Last Earnings Report?

CRISPR Therapeutics (CRSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.